PK and Drug Interaction Study of Utidelone Plus Capecitabine in Patients With Advanced Breast Cancer
Clinical trial NCT05052437 · COMPLETED
Trial details
- NCT number
- NCT05052437
- Sponsor
- Beijing Biostar Pharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-15
- Primary completion
- 2021-01-13
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.